Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX) today announced the recent launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% ...

The ciprofloxacin and dexamethasone otic suspension market had U.S. sales of approximately $118 million, per IQVIA.

Upsher-Smith introduces generic version of Ciprodex sterile Otic suspension: Maple Grove, Minnesota Upsher-Smith Laboratories, LLC (Upshe ...

Ciprofloxacin and dexamethasone otic suspension is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in Acute Otitis Externa. Amneal has ...

Hyderabad-based pharma major Dr Reddy’s Laboratories on Tuesday said it has launched Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, in the US market following approval by the US Food ...

USA: Dr. Reddy’s Laboratories Ltd today announced the launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a therapeutic equivalent generic version of Ciprodex® (ciprofloxacin 0.3 ...

- Acquisition Supports ALK's Commitment to Provide Innovative Solutions to Address the Needs of Healthcare Providers, Including ENTs, and their Patients - - OTIPRIO is a Single-dose Antibiotic ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Ciprofloxacin (Cebran Eye ) is a fluoroquinolone antibiotic, prescribed for certain types of bacterial infections such as pneumonia, urinary tract, skin, bones and joint infections. It is also used to ...

Dr Reddy’s Laboratories Ltd has launched Ciprofloxacin and Dexamethasone Otic Suspension in the US market. The products are a therapeutic equivalent generic version of Ciprodex (ciprofloxacin 0.3 per ...